Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 9/20 | 0.39 |
| ▸ | CA2 | P00918 | 9/20 | 0.39 |
| ▸ | CA9 | Q16790 | 8/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2587271 | 1.00 | SMPD1 (0.41) | SMPD1FDPSCA1CA2CA9 | |
| SCHEMBL2587280 | 1.00 | SMPD1 (0.41) | SMPD1FDPSCA1CA2CA9 | |
| SCHEMBL2577447 | 1.00 | SMPD1 (0.41) | SMPD1FDPSCA1CA2CA9 | |
| SCHEMBL10620537 | 1.00 | SMPD1 (0.41) | SMPD1FDPSCA1CA2CA9 | |
| SCHEMBL2574889 | 1.00 | SMPD1 (0.41) | SMPD1FDPSCA1CA2CA9 | |
| SCHEMBL5403778 | 0.93 | CA1 (0.37) | SMPD1FDPSCA1CA2CA9 | |
| Acetic Acid SCHEMBL9751129 | 0.89 | CES2 (0.43) | SMPD1FDPSTSHR | |
| SCHEMBL6610038 | 0.81 | CA1 (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11784627 | 0.80 | MEN1 (0.43) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14902960 | 0.79 | THRB (0.38) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8049039-B2 | Process for preparation of alkoxylated alkylamines/alkyl ether amines with peaked distribution | AKZO NOBEL N.V. (NL) | 2011-11-01 | — | — | US | claimed |
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2009-08-20 | — | — | US | claimed |
| CN-101479232-A | Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution | AKZO NOBEL NV (NL) | 2009-07-08 | — | — | CN | claimed |
| EP-2032523-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2009-03-11 | — | — | EP | claimed |
| WO-2007147866-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-12-27 | — | — | WO | claimed |
| EP-1793667-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2007-06-13 | — | — | EP | claimed |
| WO-2006034459-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2006-03-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALKBH3, ALKBH2, ALKBH5 | SMPD1 1762/4885FDPS 3512/4885CA1 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.